ABMTAdvanced BioMedical Technologies, Inc.

About Advanced BioMedical Technologies, Inc. (ABMT)

Advanced BioMedical Technologies, Inc. (ABMT) is a Medical Devices company headquartered in New York City, NY, United States whose shares trade over-the-counter on the Expert Market tier.

Advanced BioMedical Technologies, Inc. is a revolutionary new biotech company. The company has invented the newest technology in orthopaedic internal fixation devices. These devices consist of high grade polymers which have been manufactured in such a way that they allow the body to degrade the products during the bone healing process. The patented products and materials that the company has created differ from existing products (PLLA/PLA; titanium/stainless steel) being marketed today.

Products and services

We are engaged in the business of designing, developing, manufacturing and marketing of biomaterial internal fixation devices. We hold one Class III medical device permit from the National Medical Products Administration of the PRC (“NMPA”) for our product - polymer orthopaedic internal fixation screws, one Class II permit and one Class I permit. We hold four patents issued by the State Intellectual Property Office of the P.R.C. (“SIPO”). Our polyamide materials, their uses and manufacturing processes are protected by Patent No. ZL201511006236.7 and ZL971190739. Patent No. ZL201410647464.1 titled “Bone Fracture Plate Made of High Polymer Materials” and patent No. ZL201511005531.0 titled “Composite fiber, manufacturing method and orthopaedic binding wire” were granted to us in 2018 and 2020 respectively. Our polyamide materials are used in producing screws, binding wires, rods and related products. These products are used in a variety of applications including orthopaedic trauma, sports related medical treatment, or cartilage injuries, and reconstructive dental procedures.

ABMT key facts

Ticker symbol

ABMT

Market tier

Expert Market

Sector

Healthcare

Industry

Medical Devices

Headquarters

New York City, NY, United States

Country of incorporation

US

Employees

17

Estimated market cap

$28.4K (as of Apr 11, 2025)

Shares outstanding

70,904,850

Reporting standard

Dark: Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

10/31

Latest filing

Annual Report (Oct 31, 2022)

Advanced BioMedical Technologies, Inc. leadership

• Hui Wang — CEO
• Chiming Yu — President, IR
• Kai Gui — CFO, Secretary, COO

Explore more: Medical Devices stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with A